| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | travoprost (Travatan®) |
| Formulation | 40 micrograms/ml eye drops |
| Reference number | 321 |
| Indication | Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma |
| Company | Alcon Laboratories (UK) Ltd |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 12/05/2003 |